Skip to main content
Contact +1 (919) 234-1277
Nycodenz AG® Nycodenz AG® XtenCHO ™ Race Starter kit XtenCHO ™ Race Starter kit
View all Products

Filter

VEGF - VEGFR

VEGFa-VEGFR proteins are the main components of the vascular endothelial growth factor (VEGF) family of proteins. They are important for the regulation of vascular development and homeostasis. VEGF is a… Read more
Contact us
Contact us image
32 Products
Show items

Varisacumab Biosimilar – Anti-VEGFA mAb – Research Grade

QC & Validation Data
Reference

PX-TA1458
Size

100ug, 1MG
Isotype

IgG1, kappa
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
$238.00 Select options This product has multiple variants. The options may be chosen on the product page

Vanucizumab Biosimilar – Anti-ANGPT2, VEGFA, mAb – Research Grade

QC & Validation Data
Reference

PX-TA1355
Size

100ug, 1MG
Isotype

VH-C-kappa-CH2-CH3_V-lambda-CH1_H-GAMMA-1_L-kappa
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
$238.00 Select options This product has multiple variants. The options may be chosen on the product page

Brolucizumab Biosimilar – Anti-VEGFA mAb – Research Grade

QC & Validation Data
Reference

PX-TA1374
Size

100ug, 1MG
Isotype

scFv-kappa-heavy
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
$238.00 Select options This product has multiple variants. The options may be chosen on the product page

Ranibizumab Biosimilar – Anti-VEGF mAb – Research Grade

QC & Validation Data
Reference

PX-TA1008
Size

100ug, 1MG
Isotype

FabG1
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
$238.00 Select options This product has multiple variants. The options may be chosen on the product page

Bevacizumab Biosimilar – Anti-VEGF mAb – Research Grade

QC & Validation Data
Reference

PX-TA1006
Size

100ug, 1MG
Isotype

IgG1
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
$238.00 Select options This product has multiple variants. The options may be chosen on the product page

Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade

QC & Validation Data
Reference

PX-TA1016
Size

100ug, 1MG
Isotype

hG1-Fc
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
$357.00 Select options This product has multiple variants. The options may be chosen on the product page

Human FLT1 recombinant protein

QC & Validation Data
Reference

PX-P6096-100
size

100ug
Brand

ProteoGenix
Product type

Recombinant Proteins
Host Species

Mammalian cells
Applications

Elisa, WB
$500.00 Add to cart

Contact us

Send us a message from the contact form below







    VEGFa-VEGFR Proteins

    VEGFa-VEGFR proteins are the main components of the vascular endothelial growth factor (VEGF) family of proteins. They are important for the regulation of vascular development and homeostasis. VEGF is a cytokine that binds to two receptors, VEGFR-1 and VEGFR-2, which are transmembrane proteins located on the surface of endothelial cells. VEGFR-1 binds to VEGF-A, while VEGFR-2 binds to both VEGF-A and VEGF-B. The binding of VEGF to its receptors activates a number of signaling pathways that promote angiogenesis, the formation of new blood vessels. VEGF is also involved in the regulation of vascular permeability and inflammation.

    VEGFa-VEGFR Antibodies

    VEGFa-VEGFR antibodies are used to detect and quantify the levels of VEGF and its receptors in various biological samples. These antibodies can be used in immunohistochemistry (IHC), western blotting, and immunoprecipitation (IP) experiments. VEGFa-VEGFR antibodies can also be used to study the effects of VEGF on endothelial cells in vitro and in vivo.

    VEGFa-VEGFR as a Drug Target

    VEGFa-VEGFR is an attractive drug target for the treatment of cancer and other diseases. VEGF is overexpressed in many types of tumors, and its inhibition has been shown to reduce tumor growth and metastasis. VEGF inhibitors, such as bevacizumab and aflibercept, have been approved for the treatment of certain types of cancer. Other VEGF inhibitors, such as ramucirumab and nintedanib, are currently being investigated for their potential use in treating various types of cancer.

    ProteoGenix VEGFa-VEGFR Proteins

    ProteoGenix is a biotechnology company that specializes in the production of high-quality recombinant VEGFa-VEGFR proteins. ProteoGenix's VEGFa-VEGFR proteins are used in research and drug development, as well as in the production of diagnostic and therapeutic antibodies.

    Cart (0 Items)

    Your cart is currently empty.

    View Products